LinkMed is an investment company that focuses exclusively on Swedish
biotech and medtech start ups with strong commercial potential.
LinkMed has developed a step-by-step business model for growing life
science companies, based on choosing ideas with commercial
potential; investment capital; and hands-on expertise.
LinkMed has created a portfolio of twelve companies, seven in
biotechnology and five in medical technology.
The company’s principal owners are FastPartner, Koncentra Holding,
and the founder Ingemar Lagerlöf. The LinkMed share is listed on the
OMX Nordic Exchange Stockholm in the small-cap sector (ticker:LMED).